Plan to curb repeats of four common antibiotics
The AMA and RACGP are backing the proposed restrictions
Repeats of four common antibiotics would no longer be funded via the PBS under a new plan to tackle antibiotic resistance.
The PBAC proposal, released last week, recommended banning subsidies for repeat scripts of cephalexin, roxithromycin, amoxycillin and amoxycillin-clavulanic acid.
